tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AGIO Stock Latest News

Agios Pharmaceuticals Signals Confident Path After AQVESME Win
Company AnnouncementsAgios Pharmaceuticals Signals Confident Path After AQVESME Win
3d ago
AGIO
Regulatory Delays Threaten Agios Pharmaceuticals’ Drug Pipeline, Costs and Revenue Outlook
PremiumCompany Announcements
Regulatory Delays Threaten Agios Pharmaceuticals’ Drug Pipeline, Costs and Revenue Outlook
5d ago
AGIO
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
PremiumCompany Announcements
Agios Pharmaceuticals Signals Confident Path After AQVESME Win
5d ago
AGIO
Buy Rating Backed by Strong Q4 Execution, Early Aqvesme Momentum, and Multi-Asset Clinical Catalyst Upside
PremiumRatings
Buy Rating Backed by Strong Q4 Execution, Early Aqvesme Momentum, and Multi-Asset Clinical Catalyst Upside
5d ago
AGIO
Agios Pharmaceuticals files automatic mixed securities shelf
PremiumThe Fly
Agios Pharmaceuticals files automatic mixed securities shelf
5d ago
AGIO
Agios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating
PremiumRatingsAgios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating
5d ago
AGIO
Agios Pharmaceuticals reports Q4 revenue $20.0M, consensus $12.06M
Premium
The Fly
Agios Pharmaceuticals reports Q4 revenue $20.0M, consensus $12.06M
6d ago
AGIO
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
Premium
The Fly
JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
7d ago
AGIO
FULC
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8d ago
AGIO
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
PremiumCompany Announcements
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
18d ago
AGIO
Vorasidenib’s Real-World Test in Germany: What Agios Investors Should Watch
PremiumCompany Announcements
Vorasidenib’s Real-World Test in Germany: What Agios Investors Should Watch
1M ago
AGIO
Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
PremiumCompany Announcements
Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
1M ago
8K
AGIO
Agios Pharmaceuticals outlines 2026 strategic priorities
PremiumThe FlyAgios Pharmaceuticals outlines 2026 strategic priorities
1M ago
AGIO
Agios Pharmaceuticals price target raised to $35 from $34 at BofA
Premium
The Fly
Agios Pharmaceuticals price target raised to $35 from $34 at BofA
1M ago
AGIO
Agios Pharmaceuticals price target raised to $25 from $20 at JPMorgan
Premium
The Fly
Agios Pharmaceuticals price target raised to $25 from $20 at JPMorgan
1M ago
AGIO
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
PremiumRatings
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
2M ago
AGIO
Agios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
PremiumRatings
Agios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
2M ago
AGIO
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
PremiumRatings
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
2M ago
AGIO
Agios Pharmaceuticals price target raised to $62 from $48 at H.C. Wainwright
PremiumThe Fly
Agios Pharmaceuticals price target raised to $62 from $48 at H.C. Wainwright
2M ago
AGIO
Agios Pharmaceuticals price target raised to $38 from $32 at Truist
PremiumThe FlyAgios Pharmaceuticals price target raised to $38 from $32 at Truist
2M ago
AGIO
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
Premium
Market News
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
2M ago
AGIO
Agios Pharmaceuticals’ Aqvesme to be introduced at $425K per patient per year
Premium
The Fly
Agios Pharmaceuticals’ Aqvesme to be introduced at $425K per patient per year
2M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >